Fig 2

Using adjusted RSV-ICD-coded disease burden: preferred strategy based on cost-effectiveness analysis from the healthcare payers’ perspective

Note: The RSV vaccine price per dose assumed is €150. Abbreviations: QALY: quality-adjusted life-year, EUR: euro